Treatment of Asymptomatic Carriers of Plasmodium falciparum with Artemether–Lumefantrine: Impact on the Prevalence of Anemia
An investigation of whether treatment of asymptomatic carriers of Plasmodium falciparum with artemether–lumefantrine (AL), in addition to the routine treatment of symptomatic cases with AL, could improve the prevalence of anemia in 18 villages in Burkina Faso.
This was a single-center, controlled, parallel, cluster-randomized study to evaluate the effect of systematic treatment of P. falciparum asymptomatic carriers at a community level on hemoglobin (Hb) levels and anemic status of children (<5 years) and adults during four screening campaigns carried out over a 12-month period, compared with no treatment of asymptomatic carriers.
The change in Hb level in all asymptomatic carriers aged >6 months from Day 1 to Day 28 of the first campaign was +0.53 g/dl (from 11.81 to 12.33 g/dl) in the intervention arm vs. −0.21 g/dl (from 12.06 to 11.86 g/dl) in the control arm (P < 0.001). During the same period, the proportion of asymptomatic carriers aged >6 months to <5 years with anemia in the intervention arm decreased by 31.1% (from 75.7% to 44.6%), compared with a decrease of 4.7% (from 76.3% to 71.6%) in the control arm. Over 12 months, the proportion of asymptomatic carriers with anemia (mild, moderate, or severe) was reduced in both arms.
Systematic screening and treatment of asymptomatic carriers of P. falciparum with AL at the community level can reduce the prevalence of anemia in children in the short term (28 days), although the effect was not maintained at 12 months.
- Ogutu, B, Tiono, AB, Makanga, M (2010) Treatment of asymptomatic carriers with artemether–lumefantrine: an opportunity to reduce the burden of malaria?. Malar J 9: pp. 30 CrossRef
- Otten, M, Aregawi, M, Were, W (2009) Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. Malar J 8: pp. 14 CrossRef
- Bhattarai, A, Ali, AS, Kachur, SP (2007) Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 4: pp. e309 CrossRef
- Ceesay, SJ, Casals-Pascual, C, Erskine, J (2008) Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 372: pp. 1545-1554 CrossRef
- Sharp, BL, Kleinschmidt, I, Streat, E (2007) Seven years of regional malaria control collaboration—Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg 76: pp. 42-47
- Murphy, SC, Breman, JG (2001) Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 64: pp. 57-67
- Newton, CR, Warn, PA, Winstanley, PA (1997) Severe anaemia in children living in a malaria endemic area of Kenya. Trop Med Int Health 2: pp. 165-178 CrossRef
- McElroy, PD, Kuile, FO, Lal, AA (2000) Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project. Am J Trop Med Hyg 62: pp. 504-512
- Kurtzhals, JA, Addae, MM, Akanmori, BD (1999) Anaemia caused by asymptomatic Plasmodium falciparum infection in semi-immune African schoolchildren. Trans R Soc Trop Med Hyg 93: pp. 623-627 CrossRef
- Dunyo, S, Milligan, P, Edwards, T, Sutherland, C, Targett, G, Pinder, M (2006) Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. PLoS Clin Trials 1: pp. e20 CrossRef
- Baliraine, FN, Afrane, YA, Amenya, DA (2009) High prevalence of asymptomatic Plasmodium falciparum infections in a highland area of western Kenya: a cohort study. J Infect Dis 200: pp. 66-74 CrossRef
- Mabunda, S, Aponte, JJ, Tiago, A, Alonso, P (2009) A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings. Malar J 8: pp. 74 CrossRef
- Vafa, M, Troye-Blomberg, M, Anchang, J, Garcia, A, Migot-Nabias, F (2008) Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants. Malar J 7: pp. 17 CrossRef
- Dal-Bianco, MP, Koster, KB, Kombila, UD (2007) High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults. Am J Trop Med Hyg 77: pp. 939-942
- Geerligs, PD, Brabin, BJ, Eggelte, TA (2003) Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality. Bull World Health Organ 81: pp. 205-216
- Korenromp, EL, Armstrong-Schellenberg, JR, Williams, BG, Nahlen, BL, Snow, RW (2004) Impact of malaria control on childhood anaemia in Africa—a quantitative review. Trop Med Int Health 9: pp. 1050-1065 CrossRef
- Alonso, PL, Lindsay, SW, Armstrong Schellenberg, JR (1993) A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 2. Mortality and morbidity from malaria in the study area. Trans R Soc Trop Med Hyg 87: pp. 13-17 CrossRef
- Clarke, SE, Jukes, MC, Njagi, JK (2008) Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial. Lancet 372: pp. 127-138 CrossRef
- Tiono, AB, Ouedraogo, A, Ogutu, B (2013) A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso. Malar J 12: pp. 79 CrossRef
- Makanga, M, Bassat, Q, Falade, CO (2011) Efficacy and safety of artemether–lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis. Am J Trop Med Hyg 85: pp. 793-804 CrossRef
- WHO. Model List of Essential Medicines. 2002. http://www.who.int/medicines/publications/essentialmedicines/en/ Last accessed: March 8, 2013.
- Mapping Malaria Risk in Africa (MARA) Collaboration. Burkina Faso: duration of the malaria transmission season. 2012. 10-6-2010. http://www.mara.org.za/pdfmaps/BukSeasonality.PDF. Last accessed: March 8, 2013.
- De Allegri, M, Louis, VR, Tiendrebeogo, J, Souares, A, Ye, M, Tozan, Y (2013) Moving towards universal coverage with malaria control interventions: achievements and challenges in rural Burkina Faso. Int J Health Plann Manage 28: pp. 102-121 CrossRef
- Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004;(2):CD000363.
- Thuilliez, J, Sissoko, MS, Toure, OB, Kamate, P, Berthelemy, JC, Doumbo, OK (2010) Malaria and primary education in Mali: a longitudinal study in the village of Doneguebougou. Soc Sci Med 71: pp. 324-334 CrossRef
- Treatment of Asymptomatic Carriers of Plasmodium falciparum with Artemether–Lumefantrine: Impact on the Prevalence of Anemia
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Infectious Diseases and Therapy
Volume 2, Issue 1 , pp 47-58
- Cover Date
- Print ISSN
- Online ISSN
- Springer Healthcare
- Additional Links
- Asymptomatic carriers
- Infectious disease
- Plasmodium falciparum
- Author Affiliations
- 1. Centre National de Recherche et de Formation sur le Paludisme, Ministère de la Santé, O1BP 2208, Ouagadougou, Burkina Faso
- 2. Novartis Pharma AG, 4002, Basel, Switzerland
- 3. Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA